U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) June 29, 2007
-------------
GREATBATCH, INC.
----------------
(Exact name of registrant as specified in its charter)
Delaware 1-16137 16-1531026
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
9645 Wehrle Drive, Clarence, New York 14031
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (716) 759-5600
--------------
Not Applicable
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425).
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240 14a-12).
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)).
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)).
Item 1.01 Entry into a Material Definitive Agreement
On June 29, 2007, Greatbatch Ltd. ("GL"), a subsidiary of Greatbatch, Inc.
(the "Company") entered into a supply agreement with Cardiac Pacemakers,
Inc., a subsidiary of Boston Scientific Corporation ("BSC"). Under the
terms of the supply agreement, BSC has agreed to purchase from GL a certain
percentage of the batteries, capacitors, and case halves it uses in its
implantable medical devices at prices stated in the supply agreement. The
supply agreement is effective as of July 1, 2007, and the initial term of
the supply agreement ends on December 31, 2010. The agreement may be
renewed for one or more four year renewal terms upon mutual agreement of
the parties. The prices stated in the supply agreement are subject to
adjustment for changes in cost, and the prices of certain batteries and
capacitors stated in the supply agreement are subject to adjustment for
changes in volume.
The supply agreement replaces the battery supply agreement between GL and
Cardiac Pacemakers Inc. d/b/a Guidant entered into on April 10, 2003, as
amended, and replaces the capacitor supply agreement between the Company
and Guidant/CRM entered into on September 15, 2001, as amended. A pricing
letter from BSC dated January 29, 2007, as amended, is also replaced by the
supply agreement.
The Company will seek confidential treatment pursuant to Rule 24b-2 of the
Securities Exchange Act of 1934, as amended, with respect to portions of
the supply agreement and file the supply agreement with its quarterly
report on Form 10-Q for the fiscal quarter ended June 29, 2007.
Item 1.02 Termination of a Material Definitive Agreement
See Item 1.01 above, which is incorporated by reference into this section
1.02.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Dated: July 5, 2007 GREATBATCH, INC.
By: /s/ Thomas J. Mazza
-------------------------
Thomas J. Mazza
Senior Vice President and
Chief Financial Officer